olanzapine / Generic mfg. |
| Not yet recruiting | 4 | 20 | | | University of Auckland, Health Research Council | Schizophrenia, Glucose intolerance | | | | |
| Recruiting | 4 | 40 | | | Bristol Meyers Squibb Pharmaceuticals, Bristol Meyers Squibb Pharmaceuticals | Schizophrenic and schizoaffective disorder | | | | |
ACTRN12614000551695: Efficacy and tolerability of asenapine compared with olanzapine in borderline personality disorder: a randomized controlled trial |
|
|
| Recruiting | 4 | 80 | | | Centre for Personality Disorders, Psychiatric Clinic, Department of Neuroscience, University of Turin, Italy, Centre for Personality Disorders, Psychiatric Clinic 1, Department of Neuroscience, University of Turin, Italy | Borderline personality disorder | | | | |
ChiCTR2000029615: Olanzapin Versus Dexmethasone, With 5-HT3 RA and Aprepitant, to Prevent Nausea and Vomiting Induced by Full Dose Single-Day Cisplatin-Based Chemotherapy: a Non-Inferiority, Randomized, Controlled, Phase III, Multi-Center Clinical Trial |
|
|
| Not yet recruiting | 4 | 520 | | Olanzapine ;Dexmethasone | The Fifth Affiliated Hospital of Sun Yat-Sen University; The Fifth Affiliated Hospital of Sun Yat-Sen University, The Fifth Affiliated Hospital of Sun Yat-Sen University | Chemotherapy-induced Nausea and Vomitting | | | | |
ChiCTR-TNRC-10001112: The study on clinical and biological characters of bipolar depression and the treatment scheme optimizing |
|
|
| Completed | 4 | 640 | | Lithium, Sodium valproate, Lamotrigine, MECT, Sertraline, Citalopram, Escitalopram, venlafaxine, Quetiapine, Olanzapine, Risperidone, sulpiride | Guangzhou Scientific and Technological Bureau, Guangzhou Board of Health; Guangzhou first people's hospital, The Tackling Key Problems of Guangzhou Scientific and Technological Project | bipolar depressive disorder | | | | |
ChiCTR-RNC-09000522: The genetic association study on individual difference of therapeutic effects of antipsychotic medication |
|
|
| Completed | 4 | 900 | | Risperidone 2-6mg/d; Olanzapine 5-20mg/d; Aripiprazole 10-30mg/d | the Sixth Hospital, Peking University; Ministry of Science and Technology of the People′s Republic of China, Ministry of Science and Technology of the People′s Republic of China | schizophrenia | | | | |
ChiCTR-TRC-13003554: Olanzapine-valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar manic episodes: a randomized, controlled trial |
|
|
| Completed | 4 | 120 | | Taking valproate ;Taking olanzapine ;Taking olanzapine and valproate | Department of Psychiatric, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Second Affiliated Hospital of Zhejiang University School of Medicine, Technology Foundation of Zhejiang Province (2010C33038); Health Foundation of Zhejiang Province (2011KYA073); Medical Technology Program Foundation of Zhejiang Province (2012KYA101) | bipolar I disorder mania-episode | | | | |
| Completed | 4 | 3000 | | Perphenazine 16-64 mg/d (N=250) or Haloperidol 6-20 mg/d (N=250) ;Risperidone 2-6mg/d ;Olanzapine 5-20 mg/d ;Quetiapine 400-750mg/d ;Aripiperazole 10~30 mg/d ;Ziprasidone 80-160 mg/d | The Sixth Hospital / Institute of Mental Health, Peking University; The Ministry of Science and Technology, The National High Technology Research and Development Program of China (863 program) | Schizophrenia | | | | |
ChiCTR-RNC-09000521: The genetic association study on individual difference of therapeutic effects of antipsychotic medication |
|
|
| Completed | 4 | 2100 | | Risperidone 2-6mg/d; Olanzapine 5-20mg/d; Qutiapine 400-750mg/d; Ziprasidone 80-160 mg/d; Aripiprazole 10-30mg/d; Clozapine 200-600 mg/d; Perphenazine 20-60 mg/d | Sixth Hospital, Peking University; Ministry of Health, China, Ministry of Health, China. | schizophrenia | | | | |
2005-001606-66: OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS |
|
|
| Ongoing | 4 | | Europe | ZYPREXA VELOTAB*28 CPR 5 MG, LAMICTAL*25MG 28 CPR DISP., ZYPREXA VELOTAB*28 CPR 5 MG, LAMICTAL*25MG 28 CPR DISP. | AZIENDA SANITARIA OSPEDALIERA \"S. GIOVANNI BATTISTA DI TORINO\" | EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS | | | | |
2007-004897-26: Memantine for the Long Term Management of Neuropsychiatric Symptoms in Alzheimer\'s disease - MAIN-AD |
|
|
| Ongoing | 4 | 300 | Europe | Memantine, Risperidone, Ebixa, Risperdal, Zyprexa, Seroquel, Haloperidol (proprietary), Ebixa, Risperdal, Zyprexa, Seroquel, Haloperidol (proprietary) | King\'s College London, North Essex Partnership NHS Foundation Trust | Alzheimer\'s disease | | | | |
ChiCTR-OPC-15007529: Comparasion of metabolic side-effect of olanzapine or ziprasidone monotherapy, ziprasidone replacement andziprasidone joint olanzapine treatment on schizophrenia or schizophrennia like patients— an opne, controlled study |
|
|
| Not yet recruiting | 4 | 120 | | Treat with Ziprazidone ;Treat with Olanzapine ;Treat with olanzapine at the first week and then replaced by ziprazidone ;Treat with ziprazidone and olanzapine combindly | The department of psychiatry, Xijing Hospital; Xijing Hospital, From the department of psychiatry. | schizophrenia | | | | |
2018-000178-31: Metabolic Dysfunctions Associated with Pharmacological Treatment of Schizophrenia Alteraciones metabólicas asociadas al tratamiento farmacológico de la esquizofrenia |
|
|
| Ongoing | 4 | 48 | Europe | Olanzapine, Aripiprazole, Tablet, Olanzapine, Aripiprazole | Fundación para la Investigación e Innovación Biosanitaria de Asturias (FINBA), Fundación para la Investigación e Innovación Biosanitaria de Asturias (FINBA) | Schizophrenia Esquizofrenia, Schizophrenia Esquizofrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
ChiCTR-IPR-16009208: The safety of Paliperidone Extended-Release Tablets and Olanzapine in treating patients with schizophrenia |
|
|
| Recruiting | 4 | 120 | | Paliperidone Extended-Release Tablets ;Olanzapine | The Seventh People's Hospital of Shaoxing City; the seventh people’s hospital of Shaoxing City, the seventh people’s hospital of Shaoxing City | schizophrenia | | | | |
2018-002267-25: THE EFFECT OF GENETIC AND EPIGENETIC DISPOZITIONS ON THE EFFICIENCY AND SAFETY OF OLANZAPINE PSYCHOSIS THERAPY VLIV GENETICKÝCH A EPIGENETICKÝCH DISPOZIC NA ÚČINNOST A BEZPEČNOST LÉČBY PSYCHÓZ OLANZAPINEM |
|
|
| Not yet recruiting | 4 | 200 | RoW | Tablet | Fakultní nemocnice Brno, Fakultní nemocnice Brno/Masarykova univerzita | Psychoses, Psychoses, Psychiatry and Psychology [F] - Behavioral Disciplines and Activities [F04] | | | | |
2017-002406-12: HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A study comparing continuation versus discontinuation/dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis HAMLETT. Handling Antipsychotic Medication: Lange termijn evaluatie van specifiek toegepaste medicatie. Vergelijking tussen het doorgaan met antipsychotische medicatie bij patiënten die hersteld zijn van eerste psychotische episode en vroegtijdig afbouwen/stoppen. |
|
|
| Not yet recruiting | 4 | 512 | Europe | RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE, CID5073, CID135398745, CID5002, CID60795, CID3559, CID5355, CID115237, CID16362, CID213046, CID135398737, CID2159, CID5467, CID60149, CID667467, CIS5311507, Tablet, RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE | University Medical Center Groningen, ZonMw | HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation. HAMLETT vergelijkt de reguliere behandeling van patiënten in remissie na een eerste psychotische episode zoals beschreven in de richtlijnen, namelijk het continueren van antipsychotica voor minstens 1 jaar, met het vroegtijdig afbouwen/stoppen met medicatie., HAMLETT compares continuation versus early discontinuation of antipsychotic medication in patients who have recovered from their first episode of psychosis. HAMLETT vergelijkt de reguliere behandeling van patiënten die hersteld zijn van een eerste psychose, namelijk minimaal 1 jaar antipsychotica gebruiken, met vroegtijdig afbouwen/stoppn met medicatie, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
| Not yet recruiting | 4 | 60 | Europe | DM-Aripiprazole, DM-Olanzapine, DM- Quetiapine, DM-Risperidone, Tablet, Aripiprazole, Olanzapine, Quetiapine, Risperidone | Otsuka Pharmaceutical, Otsuka Pharmaceutical | Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis, Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
ChiCTR1900023483: Clinical Observation of the Efficacy and Safety of Ziprasidone Mesylate for Injection Combined with Oral Antipsychotics in the Treatment of Agitation Symptoms of Schizophrenia: A Multicenter Study in Shaanxi Area |
|
|
| Recruiting | 4 | 140 | | Ziprasidone Mesylate for Injection Combined With Olanzapine, Aripiprazole ;Ziprasidone Mesylate for Injection Sequential Olanzapine, Aripiprazole, Ziprasidone | Xi'an Mental Health Center; Xi'an Mental Health Center, Self-financing | Schizophrenia | | | | |
ChiCTR1800016707: Effects of Four Antipsychotics on Social Cognitive Function and Metabolism in Patients with Stable Schizophrenia |
|
|
| Recruiting | 4 | 275 | | clozapine ;chlorpromazine ;risperidone ;olanzapine ;no | Mental Health Center of Xuhui District Shanghai; Mental Health Center of Xuhui District Shanghai, Shanghai Municipal Commission of Health and Family Planning | schizophrenia | | | | |
ChiCTR1800018424: Olanzapine-based Quadruple or Triple Antiemetic Regimens For Prevention Multi-day Cisplatin Chemotherapy Induced-nausea and Vomiting: A Prospective Randomized Controlled Clinical Trial |
|
|
| Recruiting | 4 | 50 | | Quadruple antiemetic regimen ;Triple antiemetic regimen | Ordos Central Hospital, Inner Mongolia; Ordos Central Hospital, Inner Mongolia, Ordos Central Hospital Project | Malignant tumor | | | | |
2020-000102-28: Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia treated with the antipsychotic compounds clozapine or olanzapine? Kan tillægsbehandling med glukagonlignende peptid-1 receptoragonisten semaglutid forebygge forværring af metaboliske forstyrrelser hos prediabetiske og diabtetiske skizofrene patienter, der er i behandling med olanzapin eller clozapin? |
|
|
| Not yet recruiting | 4 | 104 | Europe | Suspension for injection in pre-filled pen, Ozempic | Mental Healt Center Copenhagen, Novo Nordisk, Region Hovedstaden Psykiatri | Schizophrenia spectrum disorder F20-F29, Mental Health Psykisk sygdom, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
ChiCTR2100048848: Effect of histamine receptor system on cognitive function and olanzapine induced weight change in schizophrenia |
|
|
| Completed | 4 | 31 | | betahistine | Beijing Huilongguan Hospital ; Beijing Huilongguan Hospital, Self-funded project | schizophrenia | | | | |
| Recruiting | 4 | 2000 | | Risperidone ;Olanzapine ;Aripiperazole ;Quetiapine | 国家科技部; Peking University Sixth Hospital, The Ministry of Science and Technology | Schizophrenia | | | | |
2021-003588-85: Individualized care with antipsychotics in patients suffering from schizophrenia spectrum disorders |
|
|
| Not yet recruiting | 4 | 100 | Europe | Olanzapine, Risperidone, Tablet, , Aripiprazole, Olanzapine, Risperidone | UCLouvain, FNRS | Schizophrenia, schizoaffective disorders,psychosis not otherwise specified, and dellusional disorders, psychosis, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
ChiCTR2100045323: Randomized controlled study of the combination regimen of Thalidomide and olanzapine + 5-HT receptor antogonist + hormonotherapy for the prevention of delayed nausea and vomiting induced by highly emetogenic chemotherapy |
|
|
| Recruiting | 4 | 140 | | Thalidomide 100mg qd1-5 ;Olanzapine 10mg d1-4 | Hainan General Hospital; Hainan general hospital, None | Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy | | | | |
ChiCTR2000036826: Association of Related Gene Polymorphisms With Cisplatin Multiday Chemotherapy-Induced Nausea and Vomiting |
|
|
| Recruiting | 4 | 198 | | Olanzapine based triple antiemetic regimen ;Aripitan based triple antiemetic regimen | Ordos Central Hospital, Inner Mongolia; Ordos Central Hospital, Inner Mongolia, Inner Mongolia Medical University projects、Innovation and Entrepreneurship Project of Ordos Health Commission、Independent scientific research project of Ordos Central Hospital | Malignant tumor | | | | |
ChiCTR2000040566: Low dose olanzapine in the prevention and treatment of carboplatin induced nausea and vomiting: a prospective randomized controlled trial |
|
|
| Recruiting | 4 | 100 | | Olanzapine based triple antiemetic regimen ;Standard two combination antiemetic regimen | Ordos Central Hospital, Inner Mongolia; Ordos Central Hospital, Inner Mongolia, Innovation and Entrepreneurship Project of Ordos Health Commission, Independent scientific research project of Ordos Central Hospital | Malignant tumor | | | | |
NCT03571126: Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer |
|
|
| Recruiting | 4 | 156 | RoW | Olanzapine, Placebos | Zunyi Medical College, Zunyi First People's Hospital, Affiliated Hospital of North Sichuan Medical College, Sichuan Cancer Hospital and Research Institute, Guizhou Provincial People's Hospital, Affiliated Hospital of Southwest Medical University | Chemotherapy-induced Nausea and Vomiting, Lung Cancer | 10/22 | 08/23 | | |
ChiCTR2200064256: Observation of olanzapine on prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy |
|
|
| Not yet recruiting | 4 | 124 | | Oral olanzapine prevents nausea and vomiting after general anesthesia | Taizhou Hospital of Zhejiang Province; Taizhou Hospital of Zhejiang Province, Self-financing | After laparoscopic cholecystectomy under general anesthesia | | | | |
ChiCTR2200059115: Observation of olanzapine on prevention of nausea and vomiting after general anesthesia in gynecological laparoscopic surgery |
|
|
| Not yet recruiting | 4 | 248 | | Oral olanzapine ;Placebo | Taizhou Hospital of Zhejiang Province; Taizhou Hospital of Zhejiang Province, self-funded | N/A | | | | |
ChiCTR2100046303: Fosapitan study on prevention of multiple-day chemotherapy with cisplatin-induced nausea and vomiting by a prospective randomized controlled trial |
|
|
| Recruiting | 4 | 192 | | Four antiemetic program(Day 1: Fosappitan 125mg orally once daily; Palonosetron 0.25mg once daily static push; Olanzapine 5mg orally once a day; Dexamethasone needle 5mg once a day static push; Day 2 and Day 3: Olanzapine 5mg orally once a day; Dexamethasone needle 5mg once daily static push) ;Three antiemetic program(Day 1: palonosetron 0.25mg once daily, dexamethasone 10mg once daily, olanzapine 5mg once daily; Day 2 and Day 3: Olanzapine 5mg orally once a day; Dexamethasone needle 5mg once daily static push) | Oncology Department, Ordos Central Hospital; Ordos Central Hospital, Ordos Central Hospital, Inner Mongolia | Malignant tumor | | | | |
NCT05646264: A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia |
|
|
| Recruiting | 4 | 220 | RoW | Agomelatine | Shanghai Mental Health Center, Tianjin Anding Hospital | Schizophrenia, Negative Symptoms in Schizophrenia | 08/23 | 08/23 | | |
NCT05213143: The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine |
|
|
| Terminated | 4 | 13 | RoW | Lurasidone | Sumitomo Pharma (Suzhou) Co., Ltd. | Schizophrenia | 11/22 | 11/22 | | |
ChiCTR2000040675: A prospective randomized controlled trial on the pervention of multiple-day chemotherapy-induced nausea and vomiting with delayed administration and standard administration |
|
|
| Not yet recruiting | 4 | 100 | | standard administration of fosapitam and/or olanzapine ;Delaied administration of fosapitam and/or olanzapine | Ordos Central Hospital, Inner Mongolia; Ordos Central Hospital, Inner Mongolia, Innovation and Entrepreneurship Project of Ordos Health Commission, Independent scientific research project of Ordos Central Hospital | Malignant tumor | | | | |
ChiCTR2200061017: Efficacy and safety of olanzapine combined with palonosetron in patients with chemotherapy-related nausea and vomiting of gastrointestinal tumors |
|
|
| Not yet recruiting | 4 | 272 | | Palonosetron 0.25 mg iv d1+Olanzapine 5mg po d1-3 ;Palonosetron 0.25 mg iv d1+Dexamethasone 5mg iv d1 | West China Hospital, Sichuan University; West China Hospital of Sichuan University, QILU PHARMACEUTICAL CO.,LTD | gastrointestinal cancer | | | | |
| Completed | 4 | 1 | RoW | electroencephalogram biofeedback, EB, electrical brain stimulation, EBS, ultra-low frequency transcranial magnetic stimulation, ULF-TMS, Sertraline Hydrochloride, SSRI, Clonazepam, Alprazolam, Metoprolol, beta blocker, Olanzapine, Pravastatin Sodium 20 MG, Sacubitril Valsartan Sodium Hydrate, ARNI | Pachankis, Yang I., M.D., First Affiliated Hospital of Chongqing Medical University | COVID-19 Vaccine Adverse Reaction | 03/24 | 03/24 | | |
NCT06133114: Psychopharmacological Treatment of Emotional Distress |
|
|
| Recruiting | 4 | 80 | US | Clonazepam, TAU, Olanzapine, Buprenorphine | Icahn School of Medicine at Mount Sinai | Suicide Crisis Syndrome, Psychological Distress | 10/26 | 10/26 | | |
NCT04892199: Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? |
|
|
| Recruiting | 4 | 104 | Europe | Semaglutide, 1.34 mg/mL, Semaglutide-placebo | Anders Fink-Jensen, MD, DMSci | Metabolic Disturbance, Schizophrenia, Type 2 Diabetes, Clozapine, GLP-1, Olanzapine | 07/24 | 12/24 | | |
ChiCTR2200063052: A comparative study of olanzapine oral solution film, ziprasidone mesylate for injection and haloperidol injection in the treatment of acute agitation symptoms of schizophrenia |
|
|
| Not yet recruiting | 4 | 60 | | Olanzapine oral dissolution film ;ziprasidone injection ;haloperidol injection | The Third Hospital of Fuyang; The Third Hospital of Fuyang, In-Hospital Funding | Schizophrenia | | | | |
NCT05590923: Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting |
|
|
| Recruiting | 4 | 104 | US | OLA group: Olanzapine, Steroid-sparing therapy, DEX group: Dexamethasone, Steroid therapy | The Guthrie Clinic | Chemotherapy-induced Nausea and Vomiting | 11/24 | 11/24 | | |
NCT05741502: An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine |
|
|
| Recruiting | 4 | 60 | US | Clozapine, Antipsychotics,Other (non-Clozapine), Including Olanzapine, Risperidone, Paliperidone, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, and all Typical antipsychotics | Ohio State University | Treatment-resistant Schizophrenia | 03/26 | 06/26 | | |
NCT05737511: Efficacy of Hydroxyzine for Patients With Panic Disorder |
|
|
| Not yet recruiting | 4 | 80 | NA | Hydroxyzine, Atarax, Vistaril, Escitalopram Oxalate, citalopram, fluoxetine, fluvoxamine, paroxetine, paroxetine CR, sertraline, venlafaxine XR,, Alprazolam, clomipramine, clonazepam, diazepam, imipramine, lorazepam, mirtazapine, reboxetine, Bupropion SR, divalproex, duloxetine, gabapentin, levetiracetam, milnacipran, moclobemide, olanzapine, phenelzine, quetiapine, risperidone, tranylcypromine | Sultan Qaboos University | Panic Disorder | 12/26 | 12/26 | | |
NCT04478838: "Extended" (Alternate Day) Antipsychotic Dosing |
|
|
| Recruiting | 4 | 120 | Canada | Risperidone, Risperdal, Olanzapine, Zyprexa, Apo-Olanzapine, Sandoz-Olanzapine | Centre for Addiction and Mental Health | Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy, Antipsychotic Agents | 09/27 | 09/28 | | |
ChiCTR2300069325: The mechanism of olanzapine-induced lipid metabolism disorders by activating ER stress PERK-CHOP signaling axis (a prospective cohort study) |
|
|
| Not yet recruiting | 4 | 600 | | N/A ;N/A | Nanchong Central Hospital; Nanchong Central Hospital, self-funded | Schizophrenia spectrum disorder | | | | |
ACTRN12621001238864p: PEAChY-M
Pharmacological Emergency management of Agitation in Children and Young people: a randomised controlled trial of intraMuscular medication |
|
|
| Not yet recruiting | 3 | 348 | | | Murdoch Children's Research Institute (MCRI), Medical Research Futures Fund Million Minds Mission administered through the Department of Health | acute severe behavioural disturbance | | | | |
ACTRN12621001238864: PEAChY-M
Pharmacological Emergency management of Agitation in Children and Young people: a randomised controlled trial of intraMuscular medication |
|
|
| Recruiting | 3 | 348 | | | Murdoch Children's Research Institute (MCRI), Medical Research Futures Fund Million Minds Mission administered through the Department of Health, Western Australia Child Research Fund, Emergency Medicine Foundation | acute severe behavioural disturbance | | | | |
O2, ChiCTR-TTRCC-14004093: Olanzapine versus aprepitant for the prevention of high dose cisplatin -induced nausea and vomiting: a randomized phase III trial. |
|
|
| Completed | 3 | 320 | | Olanzapine | The Xiangya 2nd hospital Central South University; Level of the institution:, Jiangsu Haosen pharmaceutical Limited by Share Ltd | Vomiting | | | | |
CINV, ChiCTR-IPR-14005265: Comparison of the effects of Palonosetron and Dexamethasone with and without Olanzapine to prevent the nausea and vomiting induced by 3-day cisplatin based chemotherapy in cancer patients: a multi cen |
|
|
| Recruiting | 3 | 178 | | Olanzapine + Palonosetron + Dexamethsone ;Palonositron | the Fourth Affiliated Hospital of China Medical University; the Fourth Affiliated Hospital of China Medical Un, self - provided | malignant neoplasm | | | | |
2008-005019-16: Randomized Olanzapine Clozapine Key study on Schizophrenia and Addiction in the Netherlands (ROCKSAN) |
|
|
| Ongoing | 3 | 140 | Europe | Olanzapine, clozapine, | AMC- academisch psychiatrisch centrum | A multi-centre prospective, randomized, double blind designed study examining the effectiveness and costs of clozapine compared to olanzapine in patients with schizophrenia or related psychotic disorders and co-morbid SUD. Study setting: in and out patients. Study duration: 6 months. | | | | |
2013-004881-33: Multicentre trial in to investigate the usage of antidepressant and antipsychotics (with / without approval) in patients at the age of children and adolescents Groß an gelegte, einfache offene klinische Studie mit mehreren teilnehmenden Prüfzentren zur Anwendung von Antidepressiva und Neuroleptika (mit /ohne Zulassung) |
|
|
| Ongoing | 3 | 1000 | Europe | Tablet, Abilify, Zyprexa, Leponex, Seroquel, Risperdal, Zeldox, Melneurin, Dipiperon, Saroten, Cipramil, Anafranil, Aponal, Cymbalta, Cipralex, Fluctin, Fevarin, Tofranil, Ludiomil, Remergil, Nortrilen, Paroxat, Zoloft, Stangyl, Trevilor | Universitätsklinikum Würzburg, Kompetenznetz TDM-KJP e.V., BfArM | therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2018-001514-15: Effects of early clozapine treatment on remission rates in acute schizophrenia (EARLY) Effekte der frühzeitigen Applikation von Clozapin auf die Remissionsrate bei akuter Schizophrenie |
|
|
| Not yet recruiting | 3 | 220 | Europe | Clozapin 1A-Pharma, Zyprexa Lilly, Capsule, hard | Bezirkskliniken Schwaben, DFG Grant Number HA 6091/4-1, project number: 316096538 | Schizophrenia Schizophrenie, Schizophrenia Schizophrenie, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
OFFER, NCT04536558: Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study |
|
|
| Not yet recruiting | 3 | 352 | RoW | olanzapine plus fosaprepitant-based triple regimen, placebo plus fosaprepitant-based triple regimen | Sun Yat-sen University, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy | 02/21 | 03/21 | | |
A221602, NCT03578081: Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy |
|
|
| Completed | 3 | 690 | US, RoW | Palonosetron Hydrochloride, Ondansetron Hydrochloride, Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Placebo | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Malignant Neoplasm | 11/21 | 05/23 | | |
ChiCTR2000031979: Exploration of intervention measures for olanzapine-related metabolic syndrome |
|
|
| Not yet recruiting | 3 | 90 | | Olanzapine plus berberine placebo ;Olanzapine plus berberine ;Piperone instead of olanzapine | Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Hui'ai Hospital); Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Hui'ai Hospital), 300000 | schizophrenia | | | | |
2021-005618-32: Dexamethasone, olanzapine, hemodynamics, and ventilation in cardiac surgery Dexamethason, olanzapin, hæmodynamik og ventilation til hjertekirurgi |
|
|
| Not yet recruiting | 3 | 1200 | Europe | Dexavit, Solution for injection, Tablet, Dexavit, Olanzapine | Rigshospitalet, Rigshospitalet | We investigate the efficacy of two pharmaceutical interventions for reducing mortality and organ damage, and shortening length of hospital stay in patients undergoing heart surgery (i.e. coronary artery bypass grafting and/or heart valve replacement)., Patients undergoing heart surgery are vulnerable to organ damage occurring during the operation. We investigate interventions to limit this damage., Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Recruiting | 3 | 164 | RoW | Olanzapine 5 MG, Zyprexa, Placebo | Cairo University | Anorexia | 09/22 | 09/22 | | |
2022-001865-11: A Study to Test if TV-44749 is Effective in Relieving Schizophrenia |
|
|
| Not yet recruiting | 3 | 640 | Europe | Olanzapine, TV44749, Powder and solvent for prolonged-release suspension for injection | Teva Branded Pharmaceutical Products R&D, Inc., Teva Branded Pharmaceutical Products R&D, Inc. | Schizophrenia is a serious mental disorder in which people interpret reality abnormally. It is a severely debilitating psychotic disorder characterized by positive symptoms (eg, delusions, hallucinations, and grossly disorganized behavior) and negative symptoms (eg, affective flattening, alogia, and avolition)., Schizophrenia is a mental disorder that may result in some combination of hallucinations, delusions, and extremely disordered thinking and behavior that impairs daily functioning and can be disabling, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT04833023: HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial |
|
|
| Recruiting | 3 | 72 | RoW | Haldol 2mg/ml oral solution, Olanzapine Actavis 5mg orodispersible tablet | Tan Tock Seng Hospital | Haloperidol, Advanced Cancer, Hyperactive Delirium, Olanzapine, End-stage Organ Disease | 12/24 | 12/24 | | |
NCT05403580: Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer |
|
|
| Withdrawn | 3 | 20 | NA | Olanzapine, LY 170053, Zyprexa, Zyprexa Zydis, Placebo Administration, Questionnaire Administration | Mayo Clinic, National Cancer Institute (NCI) | Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm | 12/23 | 12/24 | | |
ACTRN12621001236886: PEAChY-O
Pharmacological Emergency management of Agitation in Children and Young people: a randomised controlled trial of Oral medication |
|
|
| Completed | 3 | 348 | | | Murdoch Children's Research Institute, Medical Research Futures Fund Million Minds Mission administered through the Department of Health, Western Australia Child Research Fund, Emergency Medicine Foundation | acute severe behavioural disturbance | | | | |
NCT06200168: Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer |
|
|
| Recruiting | 3 | 370 | RoW | Electroacupuncture, Standard antiemetic treatment, Sham electroacupuncture | Jiuda Zhao | Electroacupuncture, Olanzapine-contained Four-drug Antiemetic, Nausea and Vomiting | 10/26 | 12/26 | | |
ChiCTR2100049820: Efficacy and safety of olanzapine and dexmedetomidine in the treatment of ICU delirium |
|
|
| Not yet recruiting | 3 | 166 | | Oral olanzapine ;Intravenous dexmedetomidine | Dalian Municipal Central Hospital; Dalian Municipal Central Hospital, Open Project Program of Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education | Delirium | | | | |
NCT05244577: Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer |
|
|
| Recruiting | 3 | 75 | RoW | Olanzapine Tablets, Olanzapine, Placebo | Shi Yanxia | Olanzapine, CINV, Testicular Cancer by AJCC V6 and V7 Stage, Cisplatin | 12/23 | 03/24 | | |
HELEN-009, NCT05242874: Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer |
|
|
| Completed | 3 | 442 | RoW | Fosaprepitant , Tropisetron and Olanzapine, Standard antiemetic therapy without dexamethasone, Fosaprepitant , Tropisetron, Dexamethasone and Olanzapine, Standard antiemetic therapy | Henan Cancer Hospital | Chemotherapy-induced Nausea and Vomiting | 08/23 | 08/23 | | |
NCT04503668: Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients |
|
|
| Terminated | 3 | 62 | US | Ondansetron, Dexamethasone, Neurokinin-1 Receptor Antagonist (NK1-RA), Fosaprepitant, Olanzapine, Zyprexa, Compazine | University of Michigan Rogel Cancer Center | Gynecologic Cancer | 01/24 | 03/24 | | |
OZONE-V, NCT05346731: Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents |
|
|
| Recruiting | 3 | 210 | RoW | Ondansetron, Dexamethasone, Aprepitant, Olanzapine | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Chemotherapy-induced Nausea and Vomiting | 03/24 | 08/24 | | |
NCT06314906: Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer |
|
|
| Recruiting | 3 | 370 | RoW | Electroacupuncture, Antiemetic Therapy, Sham electroacupuncture | Feixue Song | Electroacupuncture, Olanzapine-contained Four-drug Antiemetic, Nausea and Vomiting | 01/27 | 03/27 | | |
NCT05805800: Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV |
|
|
| Recruiting | 3 | 238 | RoW | 5HT3RA+Olanzapine, 5HT3RA+Olanzapine+Dexamethasone | Xingchen Peng | Chemotherapy-induced Nausea and Vomiting | 03/24 | 03/25 | | |
NCT06338683: Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer |
|
|
| Recruiting | 3 | 230 | RoW | Olanzapine 2.5 MG, Standard anti-tumor treatment, Nutritional advice | Qinghai Red Cross Hospital | Advanced Cancer, Olanzapine, Progression Free Survival | 03/27 | 03/28 | | |
NCT04939090: Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients |
|
|
| Recruiting | 3 | 360 | US | Olanzapine, Megestrol Acetate, Questionnaire Administration | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Advanced Malignant Solid Neoplasm, Anorexia, Hematopoietic and Lymphoid Cell Neoplasm | 05/26 | 12/26 | | |
NCT06200181: Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial |
|
|
| Recruiting | 3 | 87 | US | Olanzapine, Zypreza, Placebo | M.D. Anderson Cancer Center | Misuse, Opioid | 11/26 | 11/26 | | |
NCT06331520: NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens |
|
|
| Not yet recruiting | 3 | 627 | NA | Netupitant / Palonosetron Oral Capsule [Akynzeo], Olanzapine, Dexamethasone Oral | Fudan University | Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic Chemotherapy | 05/25 | 05/26 | | |
NCT05669742: Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients |
|
|
| Not yet recruiting | 3 | 40 | NA | Empagliflozin, olanzapine | Tanta University | Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics | 06/24 | 12/24 | | |
SOLARIS, NCT05693935: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia |
|
|
| Active, not recruiting | 3 | 675 | Europe, US, RoW | TV-44749 - Dose level 1, TV-44749 - Dose level 2, TV-44749 - Dose level 3, Placebo | Teva Branded Pharmaceutical Products R&D, Inc. | Schizophrenia | 03/24 | 01/25 | | |
NCT03367572: Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer |
|
|
| Completed | 3 | 1351 | US | Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, Visumetazone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Akynzeo, Olanzapine, LY 170053, Zydis, Zyprexa, Zyprexa Zydis, Placebo, placebo therapy, PLCB, sham therapy, Prochlorperazine, RP 6140, SKF-4657, Quality-of-Life Assessment, Quality of Life Assessment | University of Rochester NCORP Research Base, National Cancer Institute (NCI) | Breast Carcinoma | 02/24 | 02/24 | | |
| Recruiting | 3 | 1000 | Europe | Dexamethasone, Dexavit, Backrest elevation, Early wakeup call, Olanzapine | Christian Hassager | Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome | 09/27 | 12/27 | | |
2020-006062-36: A Phase II/III, randomized, 4-week, placebo-controlled study, designed to determine the safety, tolerability, and efficacy of evenamide (NW-3509) in patients with chronic schizophrenia. |
|
|
| Ongoing | 2/3 | 196 | Europe, RoW | Evenamide, NW3509, Capsule, hard | Newron Pharmaceuticals S.p.A., NEWRON PHARMACEUTICALS SPA, Newron Pharmaceuticals S.p.A, Newron Pharmaceuticals S.p.A., Newron Pharmaceuticals S.p.A | Chronic schizophrenia, Chronic schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
CALM 201, NCT05163717: INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD |
|
|
| Terminated | 2a | 8 | US | INP105, POD-OLZ, Placebo, POD-placebo, POD-PBO | Impel Pharmaceuticals | Agitation in Adolescents and Young Adults With ASD | 03/23 | 04/23 | | |
ACTRN12622001532796: A multicentre, cluster randomised, double cross over pragmatic clinical trial comparing the safety and efficacy of enteral olanzapine with quetiapine in critically ill patients with hyperactive delirium |
|
|
| Not yet recruiting | 2 | 1200 | | | Royal Melbourne Hospital, The Australian and New Zealand Intensive Care Foundation | critical illness, hyperactive delirium | | | | |
| Recruiting | 2 | 24 | | | The University of Technology Sydney , The University of Technology Sydney | Nausea
, Advanced Cancer | | | | |
ACTRN12619000284167: Use of the antipsychotic olanzapine to treat agitation in traumatic brain injury |
|
|
| Recruiting | 2 | 58 | | | Monash University, Monash Epworth Rehabilitation Research Centre | Traumatic brain injury, Post-traumatic amnesia, Agitation | | | | |
PATROL-II, UMIN000038644: A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer |
|
|
| Recruiting | 2 | 89 | Japan | Aloxi (palonosetron oral) - Helsinn, Otsuka, Roche, Eisai, Immedica, aprepitant oral - Generic mfg., olanzapine - Generic mfg. | Hoshi University; Division of Applied Pharmaceutical, University of Shizuoka, School of Pharmaceutical Sciences | Breast cancer;Oncology | | | | |
2006-006184-23: A randomised, double-blind, placebo- and olanzapine- controlled, parallel-group study to evaluate the efficacy and safety of 3 fixed doses of S 33138 in treatment of patients with an acute episode of Schizophrenia. A phase IIb, international, multicentre, 8-week study |
|
|
| Ongoing | 2 | 480 | Europe | S33138, ZYPREXA, S33138, Film-coated tablet, ZYPREXA | Institut de Recherches Internationales Servier | Schizophrenia | | | | |
2006-004783-31: A Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, MultiCentre, Phase IIa Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses of AZD3480 in Schizophrenic Patients on Stable Antipsychotic Monotherapy with quetiapine, risperidone or olanzapine |
|
|
| Ongoing | 2 | 50 | Europe | AZD3480, | AstraZeneca AB | Schizophrenia | | | | |
ChiCTR1800017724: Olanzapine combined with dexamethasone, and palonosetron for preventing nausea and vomiting induced by highly emetogenic chemotherapy : a phase II trial |
|
|
| Not yet recruiting | 2 | 40 | | olanzapine combined anti-nausea scheme | Chinese PLA General hospital; Chinese PLA General hospital, scientific research task of Beijing | nausea and vomiting induced by highly emetogenic chemotherapy | | | | |
OMCINV, ChiCTR1800015876: A randomized controlled clinical trial of Olanzapine or Metoclopramide combined with 5-HT3 receptor antagonist and dexamethasone for the prevention and treatment of nausea and vomiting associated with chemotherapy including Cisplatin |
|
|
| Recruiting | 2 | 150 | | olanzapine ;metoclopramide ;olanzapine combine with metoclopramide | Hunan Provincial People's Hospital; Hunan Provincial People's Hospital, The Olanzapine Tablets needed for this clinical trial is provided by the Jiangsu haosen pharmaceutical Limited by Share Ltd. | malignant tumor | | | | |
NCT02088060 / 2012-004335-23: A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients |
|
|
| Active, not recruiting | 2 | 150 | Europe | Cannabidiol, Olanzapine, Olanzapine 1A pharma, Placebo Cannabidiol, Placebo Olanzapine | Central Institute of Mental Health, Mannheim, Martin-Luther-Universität Halle-Wittenberg, Heidelberg University, Technical University of Munich, Ludwig-Maximilians - University of Munich, Glostrup University Hospital, Copenhagen | Schizophrenia | 12/24 | 06/25 | | |
NCT05202275: The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs |
|
|
| Recruiting | 2 | 43 | RoW | Olanzapine, Palonosetron, Aprepitant | Chinese Academy of Medical Sciences | Nausea, Vomiting, Head and Neck Squamous Cell Carcinoma, Radiotherapy Side Effect | 12/22 | 09/23 | | |
NCT05170919: Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients With Advanced Stage Cancer |
|
|
| Enrolling by invitation | 2 | 170 | US | Mirtazapine, Olanzapine | Englewood Hospital and Medical Center | Anorexia Nervosa With Significantly Low Body Weight | 12/22 | 12/23 | | |
CLOZ-AID, NCT04529226: Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis |
|
|
| Active, not recruiting | 2 | 75 | Europe | Clozapine, Nemex, Leponex, haloperidol, pimozide, olanzapine, risperidone, amisulpride | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Psychosis, Intellectual Disability | 01/25 | 12/25 | | |
NCT06065722: Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy |
|
|
| Recruiting | 2 | 100 | US | Akynzeo, Olanzapine | Simon Williamson Clinic, Helsinn Healthcare SA | Chemotherapy Induced Nausea and Vomiting | 12/23 | 12/23 | | |
| Recruiting | 2 | 80 | RoW | Haloperidol Solution, Olanzapine Tablets | HCA Hospice Care | Delirium, Terminal Illness | 05/24 | 05/24 | | |
NCT05705492: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 2 | 66 | US | Olanzapine, LY 170053, Zyprexa, Zyprexa Zydis, Placebo Administration, Questionnaire Administration | OHSU Knight Cancer Institute, Oregon Health and Science University, National Cancer Institute (NCI) | Advanced Malignant Solid Neoplasm | 06/25 | 12/25 | | |
| Recruiting | 2 | 180 | Europe | Cannabidiol as add-on, Placebo as add-on | Central Institute of Mental Health, Mannheim | Schizophrenia | 12/24 | 12/25 | | |
NCT03118986: RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy |
|
|
| Recruiting | 2 | 200 | Canada, US, RoW | Olanzapine, Placebo Oral Tablet | The Hospital for Sick Children, University of California, San Francisco, Children's Mercy Hospital Kansas City, St. Justine's Hospital, Columbia University, Medical University of South Carolina, CancerCare Manitoba, University of North Carolina, Chapel Hill, Nationwide Children's Hospital | Vomiting in Infants and/or Children, Nausea, Hematopoietic System--Cancer, Oncology | 03/25 | 04/25 | | |
NCT05676294: The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge From Ambulatory Surgery |
|
|
| Recruiting | 2 | 455 | US | Olanzapine, Zyprexa, Placebo | Yale University | Postoperative Nausea and Vomiting | 01/26 | 01/26 | | |
NCT04718727: Olanzapine for the Prevention of Postoperative Nausea and Vomiting |
|
|
| Completed | 1/2 | 132 | RoW | Placebo, 5 mg Olanzapine Tablets, zyprexa, 10 mg Olanzapine Tablets | Amani Hassan Abdel-Wahab | Postoperative Nausea | 02/23 | 02/23 | | |
STAMD, NCT05814640: Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) |
|
|
| Recruiting | 1/2 | 520 | RoW | Fluoxetine, Sertraline, Vortioxetine, Duloxetine, Aripiprazole, Lithium Carbonate, Olanzapine, GCBT | First Affiliated Hospital of Chongqing Medical University, The Second Affiliated Hospital of Chongqing Medical University, Children's Hospital of Chongqing Medical University, Southwest Hospital, China, Central South University | Depression, Sequestra | 12/25 | 07/27 | | |
ChiCTR-IID-17011693: A phase I trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy |
|
|
| Recruiting | 1 | 40 | | 2.5mg, 5mg, 7.5mg, 10mg, 15mg | The General Hospital of the People's Liberation Army; The General Hospital of the People's Liberation Army, fundation of China anticancer association geriatric cancer Specialized Committee | Malignant tumor | | | | |
NCT03781115: Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia |
|
|
| Recruiting | 1 | 24 | US | Ziprasidone, Geodon, Olanzapine, Zyprexa, Placebo Comparator, Placebo Oral Capsule | University of Arizona, Sidney R. Baer, Jr. Foundation | Schizophrenia | 12/22 | 01/23 | | |